{
    "nctId": "NCT01765049",
    "briefTitle": "Breast Density Change Predicting Response to Adjuvant Aromatase Inhibitor",
    "officialTitle": "Prospective Study Analyzing Value of Breast Density Change Predicting ENdocrine Therapy Response in Postmenopausal Women Taking Adjuvant ARomatase Inhibitor",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Invasive Breast Cancer, Estrogen Receptor Positive Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 260,
    "primaryOutcomeMeasure": "disease free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* ER positive invasive breast cancer Postmenopause women age 60yrs or older s/p bilateral salphingo-oophorectomy No history of menstruation and FSH\\>30mIU Planned for aromatase inhibitor Unilateral breast cancer Curative resection No evidence of distant metastasis\n\nExclusion Criteria:\n\n* Bilateral breast cancer Male breast cancer Acceptable for breast MRI Pregnancy or lactation",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}